Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Cedarville AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Cecil AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Branch AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Booneville AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Boles AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Barling AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Alma AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Fort Smith AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Subiaco AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Scranton AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.